Receptor mechanisms in antipsychotic drug action: focus on sigma receptors - PubMed (original) (raw)
Review
Receptor mechanisms in antipsychotic drug action: focus on sigma receptors
S H Snyder et al. J Neuropsychiatry Clin Neurosci. 1989 Winter.
Abstract
The principal antischizophrenic neuroleptic drugs in current clinical use act by blocking dopamine receptors, which mediate extrapyramidal side effects and tardive dyskinesia. As an alternative strategy, researchers have sought agents that do not influence dopamine receptors but whose behavioral effects in animals resemble those of neuroleptics. Some promising "new generation" candidate drugs have shown beneficial effects in schizophrenic patients in early clinical trials. These new agents share a selective, high affinity for sigma receptors, sites where psychotomimetic opiates act. A systematic screen for drugs that block sigma receptors may provide a valuable strategy in identifying novel antischizophrenic agents and in clarifying the pathophysiology of psychosis.
Similar articles
- Neuroendocrinological and neurochemical effects of sigma ligands.
Gudelsky GA, Nash JF. Gudelsky GA, et al. Neuropharmacology. 1992 Feb;31(2):157-62. doi: 10.1016/0028-3908(92)90026-l. Neuropharmacology. 1992. PMID: 1348112 - Effects of remoxipride and some related new substituted salicylamides on rat brain receptors.
Hall H, Sällemark M, Jerning E. Hall H, et al. Acta Pharmacol Toxicol (Copenh). 1986 Jan;58(1):61-70. doi: 10.1111/j.1600-0773.1986.tb00071.x. Acta Pharmacol Toxicol (Copenh). 1986. PMID: 2869639 - [The atypical neuroleptic concept].
Azorin JM, Dassa D, Jalfre M. Azorin JM, et al. Encephale. 1992 Sep;18 Spec No 3:453-7. Encephale. 1992. PMID: 1364079 French. - [Involvement of sigma receptors in schizophrenic syndromes. Pathophysiological approach].
Monnet FP. Monnet FP. Presse Med. 1993 Feb 13;22(5):218-23. Presse Med. 1993. PMID: 8099738 Review. French. - [Significance of brain nondopaminergic mechanisms for the specific action and side effects of neuroleptics].
Arushanian EB. Arushanian EB. Farmakol Toksikol. 1983 Jan-Feb;46(1):99-107. Farmakol Toksikol. 1983. PMID: 6130975 Review. Russian. No abstract available.
Cited by
- The non-apoptotic action of Bcl-xL: regulating Ca(2+) signaling and bioenergetics at the ER-mitochondrion interface.
Williams A, Hayashi T, Wolozny D, Yin B, Su TC, Betenbaugh MJ, Su TP. Williams A, et al. J Bioenerg Biomembr. 2016 Jun;48(3):211-25. doi: 10.1007/s10863-016-9664-x. Epub 2016 May 7. J Bioenerg Biomembr. 2016. PMID: 27155879 Free PMC article. - When the endogenous hallucinogenic trace amine N,N-dimethyltryptamine meets the sigma-1 receptor.
Su TP, Hayashi T, Vaupel DB. Su TP, et al. Sci Signal. 2009 Mar 10;2(61):pe12. doi: 10.1126/scisignal.261pe12. Sci Signal. 2009. PMID: 19278957 Free PMC article. Review. - Current hypotheses on sigma receptors and their physiological role: possible implications in psychiatry.
Debonnel G. Debonnel G. J Psychiatry Neurosci. 1993 Jul;18(4):157-72. J Psychiatry Neurosci. 1993. PMID: 8373754 Free PMC article. Review. - Sigma-1 receptor mediates cocaine-induced transcriptional regulation by recruiting chromatin-remodeling factors at the nuclear envelope.
Tsai SY, Chuang JY, Tsai MS, Wang XF, Xi ZX, Hung JJ, Chang WC, Bonci A, Su TP. Tsai SY, et al. Proc Natl Acad Sci U S A. 2015 Nov 24;112(47):E6562-70. doi: 10.1073/pnas.1518894112. Epub 2015 Nov 9. Proc Natl Acad Sci U S A. 2015. PMID: 26554014 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials